Incidence of Philadelphia-chromosome in acute myelogenous leukemia and biphenotypic acute leukemia patients: And its role in their outcome

Leukemia Research

Volumn 35, Issue 10, 2011, Pages 1339-1344

  Atfy, Maha ^a   Al Azizi, Nashwa M A ^a   Elnaggar, Amina M ^a  

^a Zagazig University   (Egypt)

Author keywords

Acute myeloid leukemia; Biphenotypic leukemia; Philadelphia (Ph) chromosome

Indexed keywords

AMSACRINE; CYTARABINE; DAUNORUBICIN; MYELOPEROXIDASE;

ACUTE BIPHENOTYPIC LEUKEMIA; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BCL ABL GENE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHIMERA; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DRUG MEGADOSE; ENZYME ACTIVITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; GENETIC ASSOCIATION; HUMAN; IMMUNOPHENOTYPING; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; RARE DISEASE; RISK ASSESSMENT; SURVIVAL RATE;

ADULT; AGE FACTORS; AGED; EGYPT; FEMALE; GENES, ABL; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; INCIDENCE; KARYOTYPING; LEUKEMIA, BIPHENOTYPIC, ACUTE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PHILADELPHIA CHROMOSOME; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 80052084394     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.04.011     Document Type: Article

References (20)

1. Burnett A.K. Acute myeloid leukemia: treatment of adults under 60 years. Rev Clin Exp Hematol 2002, 6:26-45.
2. Vardiman J.W., Thiele J., Arber D.A., Brunning R.D., Borowitz M.J., Porwit A., et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009, 114(5):937-951.
3. Bene M.C., Castoldi G., Knapp W., Ludwig W.D., Matutes E., Orfao A., et al. Proposals for the immunological classification of acute leukemias European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995, 9:1783-1786.
4. Borowitz M.J., Bene M.C., Harris N.L., Porwit A., Matutes E. Acute leukemias of ambiguous lineage. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 150-155. IARC Press, Lyons. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Pileri, S.A. Stein, H. Thiele, J. Vardiman (Eds.).
5. Quartarone E., Allegra A., Alonci A., Toscano G., Bellomo G., Corigliano E., et al. Imatinib myselate treatment in a patient with chemoresistant ph+ acute myeloid leukemia: possible role of Wilms' tumor gene 1. Tumori 2007, 93:230-231.
6. Kurzrock R., Kantarjian H.M., Druker B.J., Talpaz M. Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics. Ann Intern Med 2003, 138:819-830.
7. Cimino G., Pane F., Elia L., Finolezzi E., Fazi P., Annino L., et al. The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trial. Haematologica 2006, 91:377-380.
8. Jha C.B., Kucheria K., Choudhary P. Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (FISH) in chronic myeloid leukemia patients. Kathmandu Univ Med J 2006, 4(2):171-175.
9. Heim S., Mitelman F. Chromosomal and molecular genetics aberrations of tumor cells. Cancer cytogenetics 2009, Wiley-Blackwell, Hoboken, New Jersey. 3rd ed.
10. Zhao X.F., Gojo I., York T., Ning Y., Baer M.R. Diagnosis of biphenotypic acute leukemia: a paradigmatic approach. Int J Clin Exp Pathol 2010, 3(1):75-86.
11. Mitelman F. ISCN 1995: an international system for human cytogenetics nomenclature. Basel, Karger; 1995. Recommendations of the International Standing Committee on Human Cytogenetics Nomenclature. Memphic, Tennessee, USA; 1994.
12. Hassanzadeh-Nazarabadi M., Modarressi A., Miranpour H. The role of chromosomal aberration in childhood leukemia. J Sci, Islamic Republic of Iran 2004, 15(3):219-225.
13. Heerema N.A., Harbott J., Galimberti S., Camitta B.M., Gaynon P.S., Janka-Schaub G., et al. Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome. Leukemia 2004, 18:693-702.
14. Xu X.Q., Wang J.M., Lüsq, Chen L., Yang J.M., Zhang W.P., et al. Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: a case series of a Chinese population. Haematologica 2009, 94(7):919-927.
15. Al-Seraihy A.S., Owaidah T.M., Ayas M., El-Solh H., Al-Mahr M., Ali A.A., et al. Clinical characteristics and outcome of children with biphenotypic acute leukemia. Haematologica 2009, 94(12):1682-1690.
16. Keung Y.K., Beaty M., Powell B.L., Molnara I., Bussb D., Pettenatic M. Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia: retrospective study and review of literature. Leuk Res 2004, 28:579-586.
17. Paietta E., Racevskis J., Bennett J.M., Neuberg D., Cassileth P.A., Rowe J.M., et al. Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience. Leukemia 1998, 12:1881-1885.
18. Soupir C.P., Vergilio J.A., Cin P.D., Muzikansky A., Kantarjian H., Dan Jones D., et al. Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis. Am J Clin Pathol 2007, 127:642-650.
19. Jones D., Luthra R., Cortes J., Thomas D., O'Brien S., Bueso-Ramos C., et al. BCR-ABL fusion transcript types and levels and their interaction with secondary genetic change. Blood 2008, 112(13):5190-5192.
20. Gökbuget N., Hoelzer D. Treatment of adult acute lymphoblastic leukemia. Semin Hematol 2009, 46:64-75.